Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 8;23(Suppl E):E19–E24. doi: 10.1093/eurheartj/suab081

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published on behalf of the European Society of Cardiology. © The Author(s) 2021.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

The PASCAL System for mitral and tricuspid regurgitation treatment. Device key characteristics include: (i) a central spacer designed to fill the coaptation gap and minimize regurgitation; (ii) two paddles designed to minimize stress concentration on valve leaflet; (iii) device elongation featuring a slim profile for repositioning and navigation in dense cordae with reduced risk of entanglement; (iv) independent grasping and a single row of retention elements allowing optimal placement on valve leaflets. The PASCAL Ace System features narrower profile and central spacer to further optimizing patient treatment.